HubSpot just delivered one of the sharpest single-session drops in its recent history. Q1 results landed after the bell on May 7, sending the stock down 16% in a single day and 18% on the week — to close at $197.34 from $240 just five trading sessions ago.
The immediate catalyst was clear: earnings. The after-hours print on May 7 triggered the dramatic selloff. The move now places HUBS down 39% year-to-date, a brutal re-rating for a stock that many analysts had been pricing for AI-driven growth upside. The bear case — that outcome-based pricing may not meaningfully lift inbound demand, and that sales efficiency still lags most enterprise SaaS peers — has stepped squarely into focus.
Short sellers had been positioning for this before the event arrived. SI % of FF climbed from roughly 5.2% at the start of April to 7.4% by May 7 — a 43% jump in one month — making this the highest short interest in the 30-day window. The build accelerated sharply in the week of April 27, rising from around 5.9% to the current 7.4% level. Borrow remains cheap at 0.35% annualised, so the cost to establish a short position has posed no barrier. Availability is well above 1,000%, meaning the lending pool is far from constrained — there is no structural squeeze pressure developing here.
Options traders were not adding dramatically to the bearish case ahead of the print. The put/call ratio closed at 0.65 on May 8, fractionally below its 20-day average of 0.66, with a z-score near zero. That is striking given the scale of the selloff — it suggests options positioning was not heavily skewed to the downside going in, meaning the move caught at least some of the hedged community off-guard. The 52-week put/call range runs from 0.48 to 1.10, and the current reading sits well inside that range, closer to the call-dominated end.
The Street's reaction to the earnings miss was swift and coordinated. Ten analyst actions landed on May 8 alone, all in the same direction: lower. Macquarie cut from Outperform to Neutral and slashed its target from $350 to $190 — almost exactly at the current price — while Citigroup downgraded from Buy to Neutral and trimmed from $321 to $230. William Blair and Cantor Fitzgerald also stepped down to Neutral/Market Perform. Among those who held their constructive ratings, the discipline was in cutting targets heavily: JP Morgan kept Overweight but moved its target from $530 to $425, and Wells Fargo shaved from $350 to $300 while staying Overweight. The consensus rating remains technically a buy, with 22 buy ratings and 9 outperforms against just 4 holds and 1 underperform — but the aggregate mean price target has already compressed to $304, implying roughly 54% upside from current levels. Whether the Street finishes trimming estimates in coming days will determine how durable that gap looks.
Institutional holders were building positions heading into this week, which compounds the picture. T. Rowe Price grew its stake to 11.2% of shares outstanding as of March 31. Vanguard added nearly 580,000 shares in the same quarter. BlackRock and FMR added smaller increments as recently as April 30. These are passive or semi-passive flows in part, but the positioning means large institutional holders are now sitting on meaningful unrealised losses at these levels. Insider activity tells a straightforward story — founder and Executive Chairman Brian Halligan sold 8,292 shares on April 21 and another 8,500 on March 17, both well above current prices. CEO Yamini Rangan and CFO Kathryn Bueker also sold in early April. The 90-day net insider position is a net sell of roughly $9.1 million in value. None of the insider activity looks anomalous relative to typical plan-driven selling patterns, but the directional signal is unanimous.
Close peers mostly avoided the HUBS-scale damage this week. CRM and NOW fell 1-3% on the week, TEAM actually gained 3%, and DT rose more than 8%. MNDY was the only comparable to lose ground at -0.9%. The divergence underscores how much of this week's move was HUBS-specific rather than a sector-wide reset.
The next scheduled earnings event is June 15. Between now and then, what matters most is whether analyst estimate revisions — on revenue growth and operating margin — stabilise around the new price-target cluster, or continue drifting lower as the repricing of AI-driven SMB demand works through consensus models.
See the live data behind this article on ORTEX.
Open HUBS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
